Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Rang in Aktien #27022
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Aktienkurs
$0.16240909
Zuletzt synchronisiert: 2025-03-04
Marktkapitalisierung
$35.68M
Veränderung (1 Tag)
0.27%
Veränderung (1 Jahr)
0.00%
Land
CN
Handel Dali Pharmaceuticalco.,Ltd (603963)

Kategorie

Dividendenrendite-Verlauf für Dali Pharmaceuticalco.,Ltd (603963)
Dividendenrendite (TTM) von Dali Pharmaceuticalco.,Ltd (Aktienkürzel: 603963) zum 2022-12-31: 0.08%
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.24%
Dividendenrendite-Verlauf für Dali Pharmaceuticalco.,Ltd (603963) von 2012 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
2026 (TTM) 0.00% -100.00%
2023 0.06% -25.00%
2022 0.08% -84.62%
2021 0.52% 1,633.33%
2020 0.03% -94.23%
2019 0.52% -21.21%
2018 0.66% -76.00%
2017 2.75% -59.80%
2016 6.84% -18.18%
2015 8.36% -14.69%
2014 9.80% 15.70%
2013 8.47% 9,311.11%
2012 0.09% 0.00%
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber